Clinical and mycological implications of cryptococcal meningitis in Iran.
Cryptococcal meningitis
Cryptococcus neoformans
Epidemiology
Iran
Journal
Heliyon
ISSN: 2405-8440
Titre abrégé: Heliyon
Pays: England
ID NLM: 101672560
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
received:
07
03
2023
revised:
16
10
2023
accepted:
20
10
2023
medline:
1
11
2023
pubmed:
1
11
2023
entrez:
1
11
2023
Statut:
epublish
Résumé
Cryptococcal meningitis (CM) is an uncommon and severe infection that tends to affect both immunocompromised and immunocompetent hosts. To gain insights into the clinical and epidemiological characteristics of CM in Iran, this study evaluated patients with subacute or chronic meningitis referred to 15 Iranian hospitals. Relevant clinical and epidemiological characteristics of the patients were analyzed. Diagnosis of CM cases was performed by microscopic examination, culture, latex agglutination assay, lateral flow assay, and multiplex PCR on cerebrospinal fluid (CSF) samples. The isolates were processed and subjected to molecular identification and
Identifiants
pubmed: 37908716
doi: 10.1016/j.heliyon.2023.e21395
pii: S2405-8440(23)08603-6
pmc: PMC10613884
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e21395Informations de copyright
© 2023 Published by Elsevier Ltd.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Pathogens. 2023 Mar 08;12(3):
pubmed: 36986349
PLoS One. 2023 Jun 9;18(6):e0281849
pubmed: 37294775
QJM. 2006 Mar;99(3):143-51
pubmed: 16504989
J Neurotrauma. 2021 Dec;38(23):3295-3305
pubmed: 34605668
Front Microbiol. 2020 Aug 13;11:1921
pubmed: 32922377
J Infect Dis. 1993 Aug;168(2):508-10
pubmed: 8335995
Am J Emerg Med. 2020 Nov;38(11):2492.e1-2492.e3
pubmed: 32534877
J Virus Erad. 2016 Nov 28;2(Suppl 4):1-6
pubmed: 28303199
J Med Microbiol. 2020 May;69(5):712-720
pubmed: 32368996
Lancet Infect Dis. 2022 Dec;22(12):1748-1755
pubmed: 36049486
Diagn Microbiol Infect Dis. 2019 Feb;93(2):112-119
pubmed: 30377018
J Fungi (Basel). 2022 Dec 08;8(12):
pubmed: 36547617
Antimicrob Agents Chemother. 2012 Nov;56(11):5898-906
pubmed: 22948877
Lancet Infect Dis. 2017 Aug;17(8):873-881
pubmed: 28483415
J Mycol Med. 2020 Apr;30(1):100917
pubmed: 31864801
Infect Dis Clin North Am. 2021 Jun;35(2):493-514
pubmed: 34016288
J Clin Microbiol. 1992 Nov;30(11):2881-6
pubmed: 1452658
Antimicrob Agents Chemother. 2009 Jul;53(7):2804-15
pubmed: 19414582
Microorganisms. 2020 Apr 23;8(4):
pubmed: 32340403
Rev Soc Bras Med Trop. 2018 Jul-Aug;51(4):485-492
pubmed: 30133632
Ther Adv Infect Dis. 2020 Jul 08;7:2049936120940881
pubmed: 32685148
Biomark Med. 2020 Apr;14(6):459-479
pubmed: 32270693
Clin Microbiol Rev. 2020 Apr 29;33(3):
pubmed: 32349998
BMJ Case Rep. 2022 May 12;15(5):
pubmed: 35550321
BMC Neurol. 2022 Sep 10;22(1):340
pubmed: 36088290
J Fungi (Basel). 2021 Mar 30;7(4):
pubmed: 33808500
Clin Infect Dis. 2023 Oct 5;77(7):976-986
pubmed: 37235212
Rev Argent Microbiol. 2020 Jul - Sep;52(3):169-175
pubmed: 31564482
Mycopathologia. 2021 May;186(2):213-220
pubmed: 33398667
Future Microbiol. 2021 Nov;16:1251-1259
pubmed: 34674547